Extracellular PDI in thrombosis and vascular injury
- PMID: 40721812
- PMCID: PMC12302464
- DOI: 10.1186/s12959-025-00765-1
Extracellular PDI in thrombosis and vascular injury
Abstract
Protein disulfide isomerase (PDI) catalyzes the reduction, oxidation, and isomerization of disulfide bonds. Although initially discovered as an endoplasmic reticulum (ER)-residing protein, PDI has been demonstrated to play critical roles on cell surfaces and in the extracellular milieu under different pathophysiological settings. During thrombosis extracellular PDI regulates both platelet activation and coagulation, while during vascular injury PDI modulates proinflammatory neutrophil recruitment and the homeostasis of vascular cells. The identification of PDI substrates using mass spectrometry-based techniques such as mechanism-based kinetic trapping and differential cysteine alkylation has significantly advanced our understanding of the mechanisms whereby extracellular PDI regulates these pathophysiological processes. PDI may reduce or oxidize allosteric disulfide bonds and change the function of adhesive receptors, coagulation-related plasma proteins and signaling molecules that are important during thrombosis and vascular injury responses. The catalytic cysteines of PDI can also be post-translationally modified to enable PDI to transmit redox active species. This review aims to summarize the most recent advances about the roles of extracellular PDI in thrombosis and vascular injury and their mechanisms. With the discovery of novel PDI inhibitors, this body of knowledge will provide novel opportunities to develop strategies for the treatment of thrombotic and vascular diseases.
Keywords: Disulfide bonds; Protein disulfide isomerase; Thrombosis; Vascular injury.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Recent advances in vascular thiol isomerases and redox systems in platelet function and thrombosis.J Thromb Haemost. 2024 Jul;22(7):1806-1818. doi: 10.1016/j.jtha.2024.03.008. Epub 2024 Mar 20. J Thromb Haemost. 2024. PMID: 38518897 Free PMC article. Review.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Sexual Harassment and Prevention Training.2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
References
-
- Kemmink J, Darby NJ, Dijkstra K, Nilges M, Creighton TE. The folding catalyst protein disulfide isomerase is constructed of active and inactive thioredoxin modules. Curr Biol. 1997;7:239–45. 10.1016/s0960-9822(06)00119-9. - PubMed
-
- Hatahet F, Ruddock LW. Substrate recognition by the protein disulfide isomerases. FEBS J. 2007;274:5223–34. 10.1111/j.1742-4658.2007.06058.x. - PubMed
-
- Pirneskoski A, Klappa P, Lobell M, Williamson RA, Byrne L, Alanen HI, et al. Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem. 2004;279:10374–81. 10.1074/jbc.M312193200. - PubMed
Publication types
Grants and funding
- 2024AFB077/the Natural Science Fund of Hubei Province
- 2022CFA054/the Natural Science Fund of Hubei Province
- 2026631/the National Health and Medical Research Council of Australia
- WDCM2023001/2022001/the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research from the Hubei University of Medicine
- KF2024003/Key Laboratory of Chinese Medicinal Resource and Chinese Herbal Compound of the Ministry of Education
- 92169114/the National Natural Science Foundation of China
- 2018YFE0113600/the National Key R&D Program of China
- 2024130/the Undergraduate Teaching and Research Project of Huazhong University of Science and Technology
- 2025YB015/Graduate Teaching and Research Project of Huazhong University of Science and Technology
LinkOut - more resources
Full Text Sources